Bloomberg GlaxoSmithKline Plc agreed to buy biotech company Sierra Oncology for $1.9 billion as the UK drugmaker moves to strengthen its stable of medicines to fight cancer and prepares to spin off its consumer-health unit. The pharmaceutical giant will pay $55 per share in cash for California-based Sierra, a maker of targeted therapies for rare forms of cancer, GSK ...

  Bloomberg France’s economy is slowing more than previously expected as industry suffers from soaring energy costs and worsening supply constraints following Russia’s invasion of Ukraine, according to a monthly report by the central bank.

  Bloomberg Deutsche Telekom AG paid $2.4 billion to SoftBank Group Corp. to increase its stake in T-Mobile US Inc., taking it closer to its goal of holding a majority of the US division. The Bonn-based telecommunications company now holds 48.4% of the company after buying 21.2 million shares at an average price of $113 per T-Mobile share.